Guangdong Marubi Biotechnology Dividends and Buybacks
Dividend criteria checks 1/6
Guangdong Marubi Biotechnology is a dividend paying company with a current yield of 1.56%.
Key information
1.6%
Dividend yield
0.1%
Buyback Yield
| Total Shareholder Yield | 1.7% |
| Future Dividend Yield | 1.4% |
| Dividend Growth | 18.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.500 |
| Payout ratio | 94% |
Recent dividend and buyback updates
No updates
Recent updates
Calculating The Fair Value Of Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983)
Dec 09
Is Now The Time To Put Guangdong Marubi Biotechnology (SHSE:603983) On Your Watchlist?
Nov 22Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher
Sep 26Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations
Aug 30Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital
Jun 19Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet
May 29Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?
May 07Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion
Mar 27Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around
Feb 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 603983 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 603983's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
| Guangdong Marubi Biotechnology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (603983) | 1.6% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Personal Products) | 2.4% |
| Analyst forecast (603983) (up to 3 years) | 1.4% |
Notable Dividend: 603983's dividend (1.56%) is higher than the bottom 25% of dividend payers in the CN market (0.54%).
High Dividend: 603983's dividend (1.56%) is low compared to the top 25% of dividend payers in the CN market (2.09%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (93.6%), 603983's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (666.4%), 603983's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 04:04 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong Marubi Biotechnology Co., Ltd. is covered by 24 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Lei Yang | CGS International |
| Jin Li | Changjiang Securities Co. LTD. |
| Lei Yang | China Galaxy International Securities (Hong Kong) |